One AI platform for every cardiac pathway
PMcardio unifies AI-powered detection, decision support, and care coordination across acute care, screening, and longitudinal monitoring — so health systems stop buying point solutions and start running cardiac care on one platform.
One platform.
Every cardiac pathway.
PMcardio is a unified cardiac AI platform that supports the full cardiac care journey — from the first ECG in the field, through the cath lab, into long-term screening and monitoring. One deployment, one integration layer, one governance model.
- Pillar I
Unified AI models
Queen of Hearts, LVsense, Culprit Artery Prediction, Core AI, and more — all running on the same platform, analyzing the same clinical signals, with consistent explainability and evidence.
- Pillar II
End-to-end pathway coverage
Acute care, screening, monitoring, procedural analytics — PMcardio spans the full cardiac care continuum rather than serving a single moment.
- Pillar III
Enterprise-ready deployment
One integration, one contract, one security review. PMcardio connects to your existing ECG systems, EHR/CVIS, EMS systems, and communication tools — and scales across campuses and care settings without custom builds.
Six suites.
One platform.
The full cardiac care journey.
PMcardio's clinical suites cover the full spectrum of cardiac care — from acute emergency detection to longitudinal monitoring. Deploy the suites that match your priorities today, expand as your needs grow.
Acute Care Suite
AI-powered detection and pathway coordination for time-critical cardiac events — including STEMI and OMI, pulmonary embolism / RV strain, and hyperkalemia.
- stemi/OMI
- pe/RV strain
- hyperK
Echo Screening Suite
AI-powered screening for structural heart disease directly from a 12-lead ECG — detecting reduced LVEF, aortic stenosis, HCM, and other SHD conditions that traditional ECG interpretation misses.
- lvef
- aortic stenosis
- hcm
Core Diagnostics Suite
AI-powered comprehensive 12-lead ECG interpretation — rhythms, conduction abnormalities, cardiac axis, and full interval and wave measurements — the standard diagnostic read on every ECG that every other suite builds on.
- rhythm
- conduction
- axis
- measurements
Remote Monitoring Suite
AI-powered analysis of ambulatory ECG recordings — Holter monitors, cardiac patches, and other continuous monitoring devices — with automated findings and longitudinal tracking.
- holter
- cardiac patches
- arrhythmia burden
Patient Suite
AI-powered ECG interpretation for consumer wearables and patient-facing devices — extending cardiac care beyond the clinic into everyday life.
- wearable ECG Analysis
- PPG Analysis
Angio Suite
AI-powered analysis of coronary angiography — automated stenosis quantification, TIMI frame count, guide wire detection, and myocardial blush grading in near real-time.
- vessel segmentation
- stenosis quant.
- timi frames
- blush grading
One integration. Every pathway. Every site.
PMcardio fits into existing workflows — capturing critical inputs across your organization, running the right AI for each clinical context, coordinating downstream action, and measuring outcomes across every pathway you deploy.
Capture critical inputs, anywhere
Connect the platform to every point of care
PMcardio ingests ECGs, angiographic studies, and ambulatory recordings from across your network — prehospital, ED, cardiology, cath lab, inpatient, outpatient — without forcing teams into new tools or extra steps.
- ecg systems
- ehr/cvis
- ems systems
- Cath LAb systems
- Ambulatory devices
- scanned/printed records
Apply the right AI for every clinical context
Run multiple AI models on a single recording
PMcardio applies the relevant AI models to each input automatically — STEMI/OMI detection on acute ECGs, LVEF estimation on routine ECGs, angiographic quantification on cath lab studies, rhythm analysis on Holters, and more.
Coordinate action in real time
Get the right information to the right team — immediately
Route critical findings to the right clinical teams through role-based alerts, escalation rules, and shared case context — so handoffs are faster and decisions are aligned across departments and sites.
Measure performance and improve continuously
Turn pathway execution into system learning
Track pathway performance across sites, teams, and time. Use dashboards and reporting to support QA, audits, protocol optimization, and registry compliance — across every pathway you deploy.
PMcardio® powered by Queen of Hearts™ detects acute coronary occlusion on the first ECG, helping patients reach life-saving treatment hours earlier.
Built for the teams that run cardiac care
PMcardio is designed for how health systems actually operate — across departments, campuses, and leadership structures. Every role gets what they need from one shared platform.
Cardiology & Service Line Leadership
One cardiac AI platform across every site and every pathway — acute care, screening, monitoring, procedural. Standardize clinical decisions, protect resources, and expand your AI footprint without expanding your vendor list.
Emergency Department Leadership
Decision support that holds up at 3 AM with a junior resident on shift. PMcardio helps ED teams make time-critical escalation calls with confidence — across STEMI, PE, hyperkalemia, and every acute cardiac presentation.
Quality, Operations & Service Line Management
Visibility into what's actually happening across every cardiac pathway. Track performance, variation, and outcomes across all deployed suites — and turn that data into QA workflows, audit trails, and protocol improvement.
IT & Clinical Informatics
One vendor. One integration. One security review. PMcardio connects to your existing ECG systems, EHR/CVIS, EMS systems, angiographic systems, and communication tools — with governance, role-based access, and workflow alignment built in from day one.
AI-powered capabilities for
system-wide cardiac care
PMcardio brings interoperability, decision support, escalation, outcomes intelligence, and governance into one platform — purpose-built for multi-pathway, multi-site cardiac care delivery.
Validated AI for faster,
more accurate cardiac care
Backed by 25+ global validation studies, PMcardio's AI models consistently outperform standard-of-care — across detection accuracy, time-to-treatment, and outcome improvement.
See how health systems are deploying PMcardio
From multi-campus STEMI pathway standardization to structural heart disease screening — explore how health systems are using PMcardio to transform cardiac care delivery.
Trusted by 50+ health systems worldwide
From community hospitals to academic medical centers, health systems across three continents are using PMcardio to unify cardiac care and improve outcomes.
Enterprise-ready security and compliance
PMcardio is built for regulated healthcare environments — with the certifications, infrastructure, and data governance health systems require.
Regulatory clearance
CE-marked AI modules for clinical use in cardiac care.
Data encryption
End-to-end encryption in transit and at rest across all data flows.
Compliance & certifications
SOC 2 Type II, ISO 27001, GDPR and HIPAA compliant with Business Associate Agreement.
Data residency
Regional deployment options with data hosted in the US or EU to meet local regulatory requirements.
Infrastructure
Hosted on enterprise-grade cloud infrastructure with 99.9% uptime SLA and built-in redundancy.
Access & governance
Role-based access control, SSO integration, and full audit trails for every pathway action.
Trusted by clinicians and health systems worldwide
Common questions
from health systems
Everything you need to know about
deploying PMcardio across your organization.
What is PMcardio for Organizations?
PMcardio for Organizations is a unified cardiac AI platform supporting the full cardiac care journey — from acute emergency detection through screening, procedural analytics, and longitudinal monitoring. It combines multiple AI models, clinical decision support, real-time escalation, and outcomes intelligence into one deployment, integration, and governance model.
Certain AI ECG Modules are CE-marked medical devices under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules and functionality of the PMcardio platform may be available in your region.
How is PMcardio different from point-solution AI tools?
Most cardiac AI tools serve one condition or one modality. PMcardio is a platform spanning the full cardiac pathway — acute care, screening, remote monitoring, procedural analytics, and patient-facing use cases. One integration, one security review, one vendor relationship, one governance model.
Which clinical suites are available?
PMcardio is organized into six clinical suites spanning the cardiac pathway: Acute Care, Echo Screening, Core Diagnostics, Remote Monitoring, Patient, and Angio. Available today are the STEMI (Queen of Hearts™) and LVEF (LVsense™) models, alongside Core Diagnostics and ECGxplain™. Additional diagnostic capabilities — including PE/RV strain, hyperkalaemia (HyperK), aortic stenosis, HCM, wearable integrations, Holter and coronary angiogram analysis — are in active development and rolling out progressively. Health systems can start with the modules available today and add new ones as they launch.
How does PMcardio integrate with existing hospital systems?
PMcardio connects to ECG devices, EHR/CVIS, EMS systems, angiographic systems, and existing alerting and on-call tools — with live deployments across leading device manufacturers including GE HealthCare, Philips, LIFEPAK (Stryker), corpuls, and ZOLL. It can be launched from the EHR with secure links and SSO, and sends results back to clinical systems where care is documented.
How long does it take to deploy PMcardio?
Immediately — clinicians can start on day one, with no IT integration required: download the mobile or web app, log in, and begin scanning ECGs. Most health systems run a proof-of-concept on real patients within their first weeks. Scaling up — a phased rollout across departments, campuses, and suites with enterprise integrations and EHR connectivity — depends on integration scope and the number of sites and suites, but the platform is built to deliver value before that integration work even begins.
Can we start with one suite and expand later?
Yes. Most health systems start with one suite — often the Acute Care Suite for STEMI pathway standardization — and expand to additional suites as their priorities evolve. Because everything runs on the same platform, each new suite adds capability without adding vendor complexity.
Does PMcardio replace clinician judgment?
No. PMcardio's AI ECG Modules provides interpretable, clinically validated decision support designed to augment clinical judgment — not replace it. Clinicians always make the final call. The AI surfaces high-risk presentations and provides explainable reasoning that can be reviewed, taught, and audited.
What results can health systems expect?
Results vary by suite and deployment scope. Health systems using the Acute Care Suite have seen 48-minute reductions in door-to-balloon times, 92% reductions in false-positive cath-lab activations, and 6 hours faster treatment for STEMI equivalents. Echo Screening and Remote Monitoring Suites deliver value through earlier detection of previously missed conditions like reduced LVEF and subclinical SHD.
Is PMcardio secure and suitable for enterprise use?
Yes. PMcardio is built for regulated healthcare environments, with SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance. Certain AI modules within the platform are CE-marked medical devices certified under EU MDR. The platform supports regional data residency, role-based access control, SSO, and full audit trails. Visit the Trust Center for full details.
Can we try PMcardio before committing to a full deployment?
Yes. PMcardio's mobile and web app lets your team start using AI-powered ECG interpretation immediately — no IT integration, no setup project, no waiting. Clinicians download the app, log in, and start scanning real ECGs from day one. Most health systems run a proof-of-concept on their own patients and see measurable results before moving to a system-wide rollout.
Queen of Hearts
AI-powered detection of STEMI and occlusive MI — including subtle STEMI equivalents that standard criteria miss.
PMcardio for Individuals
AI-powered ECG interpretation on your phone — identify 50+ ECG findings in seconds, anywhere you practice.